We apologize for Proteopedia being slow to respond. For the past two years, a new implementation of Proteopedia has been being built. Soon, it will replace this 18-year old system. All existing content will be moved to the new system at a date that will be announced here.

Sandbox 20001

From Proteopedia

(Difference between revisions)
Jump to: navigation, search
Line 1: Line 1:
-
<Structure load='6vsb' size='350' frame='true' align='right' caption='Insert caption here' scene='Insert optional scene name here' />
+
==Your Heading Here (maybe something like 'Structure')==
 +
 
 +
<StructureSection load='6vsb' size='350' side='right' caption='COVID-19 surface spike (PDB entry [[6vsb]])' scene=''>
[[Image:COVID-19.jpeg|left|270px|thumb|COVID-19]]
[[Image:COVID-19.jpeg|left|270px|thumb|COVID-19]]
Line 22: Line 24:
* Scientists are endeavoring to find antivirals specific to the virus. Several drugs such as chloroquine, arbidol, remdesivir, and favipiravir are currently undergoing clinical studies to test their efficacy and safety in the treatment of COVID-19 in China, with some promising results summarized.<ref>PMID:32147628</ref>.
* Scientists are endeavoring to find antivirals specific to the virus. Several drugs such as chloroquine, arbidol, remdesivir, and favipiravir are currently undergoing clinical studies to test their efficacy and safety in the treatment of COVID-19 in China, with some promising results summarized.<ref>PMID:32147628</ref>.
- 
- 
</StructureSection>
</StructureSection>
== References ==
== References ==
<references/>
<references/>

Revision as of 12:05, 21 March 2020

Your Heading Here (maybe something like 'Structure')

COVID-19 surface spike (PDB entry 6vsb)

Drag the structure with the mouse to rotate

References

  1. Yan R, Zhang Y, Li Y, Xia L, Guo Y, Zhou Q. Structural basis for the recognition of the SARS-CoV-2 by full-length human ACE2. Science. 2020 Mar 4. pii: science.abb2762. doi: 10.1126/science.abb2762. PMID:32132184 doi:http://dx.doi.org/10.1126/science.abb2762
  2. Gautret, et al. "Hydroxychloroquine and azithromycin as a treatment of COVID-19: results of an open- label non-randomized clinical trial: Intl J Antimcrob Agents" (in press) 2020 [1]
  3. Dong L, Hu S, Gao J. Discovering drugs to treat coronavirus disease 2019 (COVID-19). Drug Discov Ther. 2020;14(1):58-60. doi: 10.5582/ddt.2020.01012. PMID:32147628 doi:http://dx.doi.org/10.5582/ddt.2020.01012
Personal tools